一种用户友好的递增式血液透析处方工具
本研究设计了一种仅需几行电子表格的递增式血液透析(IHD)处方工具,其核心是基于患者残肾功能(KRUn)与治疗频率确定透析剂量。在40例新入透析患者中,该工具计算的KRUn与金标准Solute-solver相比差异为0.07 ± 0.05 mL/min/35 L,临床可接受。该工具可能促进IHD的推广,并为比较IHD与标准每周三次透析的临床试验提供实用工具。
要点
- 递增式血液透析处方需根据残肾尿素清除率(KRUn)和治疗频率调整透析剂量。
- 该电子表格工具计算的KRUn与Solute-solver结果差异仅为0.07 ± 0.05 mL/min/35 L。
- 该工具用户友好,可能促进递增式血液透析的临床应用和后续临床试验。
核心结论
- 该电子表格工具能提供临床可接受的递增式血液透析处方结果。
研究设计与样本
- 研究设计了一种基于电子表格的递增式血液透析处方工具,并在40例新入血液透析患者中与Solute-solver进行比较。
主要发现
- 电子表格工具计算的KRUn与Solute-solver的差异为0.07 ± 0.05 mL/min/35 L,Bland-Altman分析显示一致性良好。
关键数值与推荐
- 递增式血液透析的透析剂量取决于患者残肾提供的归一化尿素清除率(KRUn)和治疗频率,依据Casino和Basile提出的可变目标模型。
临床怎么用
- 该工具可用于临床递增式血液透析处方,可能促进IHD的推广并为相关临床试验提供实用工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a recently heightened interest in incremental haemodialysis (IHD), the main advantage of which could likely be a better preservation of the residual kidney function of the patients. The implementation of IHD, however, is hindered by many factors, among them, the mathematical complexity of its prescription. The aim of our study was to design a user-friendly tool for IHD prescription, consisting of only a few rows of a common spreadsheet. METHODS: The keystone of our spreadsheet was the following fundamental concept: the dialysis dose to be prescribed in IHD depends only on the normalized urea clearance provided by the native kidneys (KRUn) of the patient for each frequency of treatment, according to the variable target model recently proposed by Casino and Basile (The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant 2017. 32: 182-190). The first step was to put in sequence a series of equations in order to calculate, firstly, KRUn and, then, the key parameters to be prescribed for an adequate IHD; the second step was to compare KRUn values obtained with our spreadsheet with KRUn values obtainable with the gold standard Solute-solver (Daugirdas JT et al., Solute-solver: a web-based tool for modeling urea kinetics for a broad range of hemodialysis schedules in multiple patients. Am J Kidney Dis 2009. 54: 798-809) in a sample of 40 incident haemodialysis patients. RESULTS: Our spreadsheet provided excellent results. The differences with Solute-solver were clinically negligible. This was confirmed by the Bland-Altman plot built to analyse the agreement between KRUn values obtained with the two methods: the difference was 0.07 ± 0.05 mL/min/35 L. CONCLUSIONS: Our spreadsheet is a user-friendly tool able to provide clinically acceptable results in IHD prescription. Two immediate consequences could derive: (i) a larger dissemination of IHD might occur; and (ii) our spreadsheet could represent a useful tool for an ineludibly needed full-fledged clinical trial, comparing IHD with standard thrice-weekly HD.
引用
- Casino FG, Basile C. A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant. 2018. PMID: 29315407. doi:10.1093/ndt/gfx343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。